EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Meet the Contributors →

Former Amgen Exec Sersch Joins Mustang Bio as Chief Medical Officer

Frank Vinluan

October 15th, 2018

Xconomy New York — 

Mustang Bio (NASDAQ: MBIO) has appointed Martina Sersch to serve as chief medical officer. Sersch comes to New York-based Mustang from Amgen (NASDAQ: AMGN), where she was executive director. Mustang is developing cell therapies to treat cancer and gene therapies to treat rare, genetic disorders.

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at fvinluan [[at]] xconomy.com. Follow @frankvinluan

More from EXOME

Trending on Xconomy

The Feed

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.